Alimera Sciences Inc.

Industry

  • Medical Devices
    • Implantable Devices
  • Biotechnology
  • Pharmaceuticals
    • Drug Delivery
      • Site Specific
      • Controlled Release
    • Specialty Pharmaceuticals

Other Names/Subsidiaries

  • Alimera Sciences
  • Alimera Sciences B.V
See more in Biomedtracker

Latest on Alimera Sciences Inc.

Scrip

Finance Watch: Actuate Launches 15th Biopharma IPO In The US For 2024

 
• By Mandy Jackson

Actuate Therapeutics, Inc. grossed $22.4m from its initial public offering of 2.8 million shares priced at $8 each in the 15th biopharmaceutical company IPO in the US in 2024. It was not the smallest

Scrip

Deal Watch: Lilly Partners With OpenAI On Drug-Resistant Pathogens

 
• By Joseph Haas

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Lilly The Latest Pharma Company To Sign

Scrip

Deal Watch: Novartis Acquires Gene Therapy Candidate From AvroBio

 
• By Joseph Haas

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Novartis Buys Cystinosis Gene Therapy F

Scrip

Deal Watch: Japan’s JCR Inks Pacts With Sumitomo Dainippon, Alexion

 
• By Joseph Haas, Lisa Takagi, Jung Won Shin, and Ian Haydock

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. JCR Signs Deal With Sumitomo On Izcargo